ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vallejo, J. L.
Right arrow Articles by Arcas, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vallejo, J. L.
Right arrow Articles by Arcas, R.

Ann Thorac Surg 1990;50:429-436
© 1990 The Society of Thoracic Surgeons

Articles

Eight years' experience with the Medtronic-Hall valve prosthesis

J.L. Vallejo, PhD*, J.M. Gonzalez-Santos, MD, J. Albertos, MD, M.J. Riesgo, MD, M.E. Bastida, MD, M.J. Rico, MD, F. Gonzalez-Diego, MD, R. Arcas, PhD

Departments of Cardiac Surgery and Anaesthesia, General Hospital Gregorio Maranon, School of Medicine, Universidad Complutense, Madrid, Spain

Accepted for publication April 9, 1990.

* Address reprint requests to Dr Vallejo, Pez Volador 28, 28007 Madrid, Spain.

During the period January 1981 to September 1986, 444 Medtronic-Hall heart valve prostheses were implanted in 351 patients (mean age, 45 ± 10 years) mainly for rheumatic valve disease (63.2%). Most of the patients were in New York Heart Association functional class III. Concomitant surgical procedures, mainly conservative tricuspid or mitral procedures or coronary artery bypass grafting, were performed in 101 patients (28.7%). Single-valve replacement was performed in 262 patients (74.6%) (aortic in 117 patients, mitral in 143, and tricuspid in 2), double-valve replacement in 85 (24.2%) (mitral and aortic in 83 and mitral and tricuspid in 2), and triple-valve replacement in 4 (1.1%). Hospital mortality was 6.2%. Follow-up was 97.7% complete. The overall actuarial 8-year survival rate was 77.2%. The linearized incidence of valve-related complications was as follows: thromboembolism, 1.5%/patient-year; reoperation, 1.5%/ patient-year; endocarditis, 1.25%/patient-year; hemolysis, 0.52%/patient-year; anticoagulant-related hemorrhage, 0.39%/patient-year; and noninfection-related paraprosthetic leak, 0.33%/patient-year. There were no instances of structural failure. We conclude that after 8 years of follow-up, the Medtronic-Hall valve prosthesis has an excellent clinical performance and a low range of valve-related complications.




This article has been cited by other articles:


Home page
 ChestHome page
D. N. Salem, P. T. O'Gara, C. Madias, and S. G. Pauker
Valvular and Structural Heart Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest, June 1, 2008; 133(6_suppl): 593S - 629S.
[Abstract] [Full Text] [PDF]

Home page
 Card Surg AdultHome page
T. Gudbjartsson, T. Absi, and S. Aranki
Mitral Valve Replacement
Card. Surg. Adult, January 1, 2008; 3(2008): 1031 - 1068.
[Full Text]

Home page
 ChestHome page
D. N. Salem, P. D. Stein, A. Al-Ahmad, H. I. Bussey, D. Horstkotte, N. Miller, and S. G. Pauker
Antithrombotic Therapy in Valvular Heart Disease--Native and Prosthetic: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest, September 1, 2004; 126(3_suppl): 457S - 482S.
[Abstract] [Full Text] [PDF]

Home page
 Card Surg AdultHome page
T. Gudbjartsson, S. Aranki, and L. H. Cohn
Mechanical/Bioprosthetic Mitral Valve Replacement
Card. Surg. Adult, January 1, 2003; 2(2003): 951 - 986.
[Full Text]

Home page
 Ann. Thorac. Surg.Home page
Y. Soga, H. Okabayashi, T. Nishina, S. Enomoto, I. Shimada, T.-A. Miyamoto, and T. Ban
Up to 8-year follow-up of valve replacement with CarboMedics valve
Ann. Thorac. Surg., February 1, 2002; 73(2): 474 - 479.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
P. D. Stein, J. S. Alpert, H. I. Bussey, J. E. Dalen, and A. G.G. Turpie
Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves
Chest, January 1, 2001; 119(2009): 220S - 227S.
[Full Text] [PDF]

Home page
 Asian Cardiovasc. Thorac. Ann.Home page
S. K. Choudhary, A. Mathur, P. Venugopal, B. Airan, R. Sharma, A. Bhan, A. Saxena, A. Sampath Kumar, S. K. Choudhary, A. Mathur, et al.
Prosthesis Size in Aortic Valve Replacement: Surgeon-Related Variable
Asian Cardiovasc Thorac Ann, December 1, 2000; 8(4): 333 - 338.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. L. Zellner, J. M. Kratz, A. J. Crumbley III, M. R. Stroud, S. M. Bradley, R. M. Sade, and F. A. Crawford Jr
Long-term experience with the St. Jude medical valve prosthesis
Ann. Thorac. Surg., October 1, 1999; 68(4): 1210 - 1218.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
A. C. Fiore, H. B. Barner, M. T. Swartz, L. R. McBride, A. J. Labovitz, K. J. Vaca, J. St. Vrain, G. L. Grunkemeier, and G. C. Kaiser
Mitral valve replacement: randomized trial of St. Jude and Medtronic Hall prostheses
Ann. Thorac. Surg., September 1, 1998; 66(3): 707 - 713.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
A. E. Fiane, O. R. Geiran, and J. L. Svennevig
Up to eight years' follow-up of 997 patients receiving the CarboMedics prosthetic heart valve
Ann. Thorac. Surg., August 1, 1998; 66(2): 443 - 448.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
T. E. David, V. L. Gott, L. A. Harker, G. E. Miller Jr, D. C. Naftel, A. G. G. Turpie, and C. W. Akins
Mechanical Valves
Ann. Thorac. Surg., November 1, 1996; 62(5): 1567 - 1570.
[Full Text]

Home page
 Ann. Thorac. Surg.Home page
C. W. Akins
Results with mechanical cardiac valvular prostheses
Ann. Thorac. Surg., December 1, 1995; 60(6): 1836 - 1844.
[Abstract] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
R. G. Masters, A. L. Pipe, V. M. Walley, and W. J. Keon
Comparative results with the St. Jude Medical and Medtronic Hall mechanical valves
J. Thorac. Cardiovasc. Surg., September 1, 1995; 110(3): 663 - 671.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
A. C. Fiore, M. T. Swartz, T. G. Sharp, K. A. Kesler, H. B. Barner, K. S. Naunheim, G. L. Grunkemeier, D. A. Moroney, and G. C. Kaiser
Double-valve replacement with Medtronic-Hall or St. Jude valve
Ann. Thorac. Surg., May 1, 1995; 59(5): 1113 - 1119.
[Abstract] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
S. Aoyagi, A. Oryoji, Y. Nishi, K. Tanaka, K. Kosuga, and K. Oishi
Long-term results of valve replacement with the St. Jude Medical valve
J. Thorac. Cardiovasc. Surg., December 1, 1994; 108(6): 1021 - 1029.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
J. M. Kratz, F. A. Crawford, R. M. Sade, A. J. Crumbley, and M. R. Stroud
St. Jude prosthesis for aortic and mitral valve replacement: A ten-year experience
Ann. Thorac. Surg., September 1, 1993; 56(3): 462 - 468.
[Abstract] [PDF]

Home page
 Eur J Cardiothorac SurgHome page
K. V. Hall
The Medtronic-Hall valve: a design in 1977 to improve the results of valve replacement
Eur J Cardiothorac Surg, January 1, 1992; 6(Supplement_1): S64 - S67.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
P. J. K. Starek
The Medtronic-Hall valves: Frequently used, seldom reported
Ann. Thorac. Surg., September 1, 1990; 50(3): 346 - 347.
[PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1990 by The Society of Thoracic Surgeons.